Celiac vs Gluten Sensitivity: Symptoms and Genetics

You feel bloated after eating bread. Fatigued after pasta. Maybe you get abdominal cramps, diarrhea, or brain fog. You search online and find two possible explanations: celiac disease or gluten sensitivity. Both involve symptoms triggered by gluten. Both are real medical conditions.

But they are fundamentally different in mechanism, severity, diagnosis, and what you need to do about them. Confusing the two can lead to unnecessary dietary restrictions on one hand or missed autoimmune damage on the other. This guide explains the actual differences, how to figure out which one applies to you, and where genetic testing fits in.

What Is Celiac Disease?

Celiac disease is an autoimmune condition. When someone with celiac eats gluten (a protein found in wheat, barley, and rye), their immune system attacks the lining of the small intestine. Specifically, it destroys the villi — tiny finger-like projections that absorb nutrients from food.

This is not an intolerance or a sensitivity. It is an immune system malfunction where your body treats a food protein as a threat and damages its own tissue in response. Over time, untreated celiac disease leads to:

• Nutrient malabsorption — iron deficiency anemia, vitamin D deficiency, calcium deficiency, and folate deficiency are common because damaged villi cannot absorb these nutrients effectively
• Bone density loss — osteoporosis and osteopenia from chronic calcium and vitamin D malabsorption
• Increased cancer risk — untreated celiac disease is associated with elevated risk of intestinal lymphoma and other GI cancers
• Neurological complications — peripheral neuropathy, ataxia, and cognitive issues in some patients
• Reproductive issues — infertility, recurrent miscarriage, and low birth weight have been associated with untreated celiac disease

Celiac disease affects approximately 1% of the global population, but the majority of cases are believed to be undiagnosed — partly because symptoms can be subtle or atypical (fatigue and joint pain without obvious GI symptoms, for example).

The Genetic Requirement: HLA-DQ2 and HLA-DQ8

Celiac disease has a strict genetic prerequisite. You must carry either the HLA-DQ2 gene (specifically DQ2.5, encoded by HLA-DQA1*05 and HLA-DQB1*02) or HLA-DQ8 (encoded by HLA-DQA1*03 and HLA-DQB1*03:02) to develop celiac disease. Without one of these genes, your immune system cannot mount the specific response that causes celiac — it is biologically impossible.

About 30–40% of the general population carries HLA-DQ2 or HLA-DQ8, but only about 3% of carriers actually develop celiac disease. Carrying the gene is necessary but not sufficient — environmental triggers (viral infection, stress, pregnancy) also play a role in disease activation.

This creates a powerful screening tool: over 99% of confirmed celiac patients carry at least one of these genes, so clinical HLA typing that finds neither is highly reassuring — among the highest negative predictive values of any test in medicine. (As discussed below, a consumer DNA screening result is informative but not the same as clinical HLA typing.)

What Is Non-Celiac Gluten Sensitivity?

Non-celiac gluten sensitivity (NCGS) is a condition where eating gluten triggers symptoms — bloating, abdominal pain, diarrhea, fatigue, brain fog, headaches — without the autoimmune intestinal damage that defines celiac disease.

NCGS is a real condition recognized by gastroenterologists, but it differs from celiac in several important ways:

• No autoimmune mechanism. The small intestine is not damaged. There is no villous atrophy and no increased cancer risk.
• No specific genetic marker. NCGS can occur in people with or without HLA-DQ2/DQ8. The presence or absence of these genes does not predict NCGS.
• No definitive diagnostic test. NCGS is diagnosed by exclusion — you rule out celiac disease, rule out wheat allergy, and if symptoms improve on a gluten-free diet and return when gluten is reintroduced, NCGS is the likely diagnosis.
• Uncertain prevalence. Self-reported gluten or wheat sensitivity is common — a 2025 global meta-analysis found a pooled rate of about 10% (ranging from under 1% to over 30% depending on the country), because there is no biomarker to test for and self-diagnosis is common. But when suspected NCGS is tested with a blinded, placebo-controlled gluten challenge, only a minority of cases have their symptoms confirmed as gluten-specific, so the rate of clinically confirmed NCGS is likely much lower than self-report surveys suggest.
• Symptoms may not be gluten-specific. Some research suggests that FODMAPs (fermentable carbohydrates found in wheat) rather than gluten itself may cause symptoms in a subset of people diagnosed with NCGS.

The practical implication: NCGS is real and can significantly affect quality of life, but it does not cause the long-term organ damage that celiac disease does. The treatment approach and urgency are different.

The Key Differences: Celiac vs. Gluten Sensitivity

What Genetic Testing Can Tell You

HLA-DQ2/DQ8 screening is the single most useful first step if you suspect celiac disease. Here is why:

If you do NOT carry HLA-DQ2 or HLA-DQ8: Celiac disease is essentially ruled out — clinical HLA typing has one of the highest negative predictive values of any test in medicine, because over 99% of confirmed celiac patients carry at least one of these genes. A clinical negative means you do not need a biopsy, you do not need to stay on a gluten-containing diet for testing purposes, and you can focus on other explanations for your symptoms (NCGS, IBS, FODMAP intolerance, wheat allergy).

If you DO carry HLA-DQ2 or HLA-DQ8: Celiac disease is genetically possible. This does not mean you have it — only about 3% of carriers develop celiac — but the next step is a TTG-IgA blood test. Critically, you must still be eating gluten when this blood test is done. If you have already gone gluten-free, the antibodies may have dropped below detectable levels and the test can produce a false negative.

This is why genetic testing is particularly valuable for people who have already started a gluten-free diet before getting a diagnosis. The genetic result is not affected by your current diet — HLA-DQ2/DQ8 status is fixed at birth.

If you have 23andMe or AncestryDNA raw data, the HLA-DQ2/DQ8 markers are typically included as tag SNPs in the genotyping panel — a proxy for the haplotypes above, not direct clinical HLA typing. DecodeMyBio's Celiac & Gluten Screening extracts and interprets these tag SNPs from your existing data, but because it is not equivalent to clinical HLA typing, a negative result should not, by itself, be used to rule out celiac disease — free to start, results in minutes. View a sample → to see exactly what is included.

Should You Go Gluten-Free?

The answer depends entirely on which condition you have:

If you have celiac disease: A strict, lifelong gluten-free diet is medically necessary. Even small amounts of gluten — a few breadcrumbs, shared cooking oil, malt flavoring in a sauce — can trigger intestinal damage whether or not you feel symptoms. This is not optional, and it is not about how you feel. Asymptomatic intestinal damage is common in celiac disease.

If you have NCGS: Gluten reduction is reasonable but strict elimination may not be necessary. Many people with NCGS tolerate small amounts of gluten without significant symptoms. The goal is symptom management, not preventing organ damage. Some people with NCGS also find that a low-FODMAP diet is more effective than a gluten-free diet, since the actual trigger may be fermentable carbohydrates rather than gluten protein.

If you have neither condition: There is no established health benefit to going gluten-free. Gluten-free products are often lower in fiber and certain B vitamins than their gluten-containing equivalents. Unless you have a medical reason, a gluten-free diet is not inherently healthier.

The most important thing is to not self-diagnose. If you suspect celiac disease, get tested before going gluten-free — otherwise you may make the diagnostic process significantly more complicated. For more on this decision, read our guide on whether you should go gluten-free based on your genetics.

Beyond Gluten: Nutrition Genetics

If you are investigating how your body handles dietary components, the genetics of nutrient metabolism extend well beyond gluten and celiac disease:

• MTHFR — variants in this gene affect folate metabolism and methylation. The C677T variant is present in about 10% of the population as homozygous (TT) and reduces enzyme activity by up to 70%. This is particularly relevant if celiac disease has already impaired your folate absorption.
• FUT2 — affects gut microbiome composition and is associated with vitamin B12 status. Non-secretor variants — carried by about 20% of people of European ancestry, with different frequencies in other populations — are linked to higher circulating B12 levels in population studies, likely reflecting altered absorption and transport rather than better B12 status.
• VDR — variants in the vitamin D receptor gene affect how efficiently your body uses vitamin D. Combined with celiac-related malabsorption, this can significantly compound bone density risk.

Nutrigenomics covers these genes and others that affect how your body processes nutrients. DecodeMyBio's Nutrition & Methylation reads MTHFR, LCT, HFE and related markers from the same raw DNA data — a useful complement to celiac screening.